drugset / Trial / NCT00733538

Stage I Multiple Myeloma Treatment

NCT00733538

Phase 4 Completed 89 enrolled Centre Hospitalier Universitaire de Nice
RandomizedFactorialOpen-labelTreatment

Summary

* Assessment of survival without progression of stage I MM in two groups: arm A: simple survey and arm B: administration of Zoledronate. * Describe different progression's type noticed and define the prognosis factors of a fast evolution.

Timeline

Start
2004-12
Primary completion
2009-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Zoledronic acid Other / unclassified

Indications